Introduction The treatment landscape of hepatocellular carcinoma (HCC) has significantly
changed over the last 5 years with multiple options in the frontline, second line, and beyond …

Percutaneous treatment of hepatocellular carcinoma (HCC) encompasses a vast range of
techniques, including monopolar radiofrequency ablation (RFA), multibipolar RFA …

Regorafenib is a diphenylurea oral multikinase inhibitor, structurally comparable to
sorafenib, which targets a variety of kinases implicated in angiogenic and tumor growth …

Background Laparoscopic liver resection for hepatocellular carcinoma (HCC) in Child–Pugh
A cirrhosis has been demonstrated as beneficial. However, the role of laparoscopy in Child …

Background & Aims To compare the overall survival (OS) and disease progression free
survival (PFS) in patients with advanced hepatocellular carcinoma (Ad-HCC) who are …

Background & Aims Antiviral therapy improves the clinical outcomes of patients with chronic
hepatitis B (CHB), including those with cirrhosis. In the present study, we validated the …

Background & Aims Treatment allocation in patients with hepatocellular carcinoma (HCC)
on a background of Child-Pugh B (CP-B) cirrhosis is controversial. Liver resection has been …

The aim of any oncological treatment is not just to eliminate the tumour, but to maximise
patient survival and quality of life. Since the liver has a vital function, any radical treatment …

Aim: We investigated the efficacy and safety of hepatic artery infusion chemotherapy (HAIC)
combined with anti-PD-1 immunotherapy and tyrosine kinase inhibitors (TKIs) for advanced …

This systematic review and meta-analysis reports on outcomes and hepatic toxicity rates
after stereotactic body radiation therapy (SBRT) for liver-confined hepatocellular carcinoma …